3654 results for «600»

Filter By

3654 results

Acute stroke interventions

11 Oct 2025 – From AICT-AsiaPCR 2025

This session provides an in-depth look at acute stroke interventions from a vascular and interventional cardiology perspective. It covers cerebral vascular anatomy relevant to stroke, various mechanical thrombectomy techniques, and the expanding role of interventional cardiologists in acute stroke management, illustrated through case presentations.

Calcium modification and atherectomy

11 Oct 2025 – From AICT-AsiaPCR 2025

This session addresses the challenges of calcium modification and atherectomy in complex coronary interventions. It features case studies on stent deformation, advanced calcium modification strategies including orbital and laser atherectomy, imaging-guided approaches, and management of complications such as stent dislodgement, offering comprehensive insights into contemporary techniques...

TAVI and aortic valve procedures

11 Oct 2025 – From AICT-AsiaPCR 2025

Focusing on transcatheter aortic valve interventions, this session covers a broad spectrum of complex cases including emergent TAV-in-SAV procedures, management of severely calcified bicuspid valves, zero-contrast TAVI techniques, and strategies for hostile anatomies. It provides valuable insights into procedural planning and follow-up to optimize patient care...

Valve-in-valve in degenerated surgical bioprothesis mitral valve - LIVE Case

10 Oct 2025 – From AICT-AsiaPCR 2025

A 78-year-old male with a history of rheumatic disease underwent surgical mitral valve replacement (Perimount Magna 25), surgical aortic valve replacement (Perimount Magna), and CABG (LIMA–LAD) in 2010. He presented with symptomatic severe mitral regurgitation and normal LV function.

He was treated with implantation of a 26...

Valve-in-valve in degenerated surgical bioprothesis mitral valve - LIVE Case

IVUS or OCT? Choosing the right imaging for the right lesion - A case-based debate

10 Oct 2025 – From AICT-AsiaPCR 2025

This case-based debate examines the complementary roles of IVUS and OCT imaging modalities in precision PCI. It highlights lesion-specific factors guiding modality choice, including left main disease, bifurcations, calcified plaques, and acute coronary syndromes, supported by real-world clinical cases demonstrating imaging-based decision-making.

EuroPCR 2018 Opening Ceremony and Ethica Awards

22 May 2018 – From EuroPCR 2018

Join J. Fajadet and W. Wijns for the EuroPCR 2018 Opening Ceremony and find out who this year's Ethica Awards winners are!

EuroPCR 2018 Opening Ceremony and Ethica Awards

CTO PCI in images and case examples: what is new in 2026?

07 Jul 2026

Register for free to this webinar on Monday 31 August at 6:00pm with K. Mashayekhi, M. Ayoub and C. Ungureanu and learn to review the recent evidence on expected outcomes after CTO PCI, and much more!

CTO PCI in images and case examples: what is new in 2026?

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

27 Oct 2023

Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

The greatest advance in the next 40 years would be to remove the need for angioplasty

17 May 2017

Spencer B. King performed some of the first coronary angioplasty procedures in the USA—having recently received a thank-you from the first patient that he treated. He tells The Daily Wire that the steerable guidewire, rather than the stent, was the greatest advance in angioplasty and that...

Authors :

Spencer B. King
Spencer B. King

ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI

28 Mar 2026

Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide percutaneous coronary intervention

COVID-19 vaccines: Burning questions from the community and real-world applicability

13 Jan 2021

View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.

COVID-19 vaccines: Burning questions from the community and real-world applicability

From PROTECT-AF to CHAMPION-AF: Where do we stand today?

01 Jul 2026

In this article, Jens Erik Nielsen-Kudsk reviews the evolution of left atrial appendage closure, from early trials such as PROTECT‑AF to recent evidence including CHAMPION‑AF, and discusses its expanding role in stroke prevention for atrial fibrillation.

Jens-Erik-Nielsen-Kudsk

Author

Jens Erik Nielsen-Kudsk
From PROTECT-AF to CHAMPION-AF: Where do we stand today?

A randomized, placebo-controlled trial of chronic total occlusion PCI in stable angina - ORBITA-CTO trial

03 Apr 2026

Kalaivani Mahadevan provides an in-depth analysis of the ORBITA-CTO trial: a first-ever randomised, double-blind, placebo-controlled trial evaluating CTO PCI in stable angina patients.
She also interviewed principal investigators Sarosh Khan and John Davies following the LBCT Scientific Session at ACC.26 in New Orleans and simultaneous publication in...

John Davies

Author

John Davies
Kalaivani Mahadevan

Author

Kalaivani Mahadevan
Sarosh Khan

Author

Sarosh Khan
ORBITA-CTO: Chronic total occlusion PCI in stable angina

The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation

01 Sep 2025

Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.

Author

Chiara De Biase
The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]
Didn’t find what you were looking for?